Phenotypes indicating cytolytic properties of Borrelia-specific interferon-γ secreting cells in chronic Lyme neuroborreliosis

Journal of Neuroimmunology

Volumn 145, Issue 1-2, 2003, Pages 115-126

  Ekerfelt, C ^a,d   Jarefors, S ^a   Tynngard N ^a   Hedlund, M ^a   Sander, B ^b   Bergstrom S ^c   Forsberg, P ^a   Ernerudh, J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Borrelia; CD8+ cells; Cytotoxic cells; Interferon ; TCR + T cells

Indexed keywords

ANTIGEN; BORRELIA BURGDORFERI ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG;

ACRODERMATITIS; ADULT; AGED; ANALYTIC METHOD; ANTIGEN EXPRESSION; ARTICLE; BLOOD CELL; BORRELIA; BORRELIA BURGDORFERI; CELL SECRETION; CELL TYPE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INTERFERON PRODUCTION; LYME DISEASE; MALE; MONONUCLEAR CELL; PATHOGENESIS; PATIENT; PHENOTYPE; PRIORITY JOURNAL; TISSUE INJURY;

EID: 0345171686     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.08.037     Document Type: Article

References (71)

1. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., Friese M., Schröder R., Deckert M., Schmidt S., Ravid R., Rajewsky K. Clonal expansion of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192:2000;393-404.
2. Baig S., Olsson T., Höjeberg B., Link H. Cells secreting antibodies to myelin basic protein in cerebrospinal fluid of patients with Lyme neuroborreliosis. Neurology. 41:1986;581-587.
3. Balmelli T., Piffaretti J.-C. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res. Microbiol. 146:1995;329-340.
4. Beermann C., Wunderli-Allenspach H., Groscurth P., Filgueira L. Lipoproteins from Borrelia burgdorferi applied in liposomes and presented by dendritic cells induce CD8+ T-lymphocytes in vitro. Cell. Immunol. 202:2000;124-131.
5. Berglund J., Eitrem R., Ornstein K., Lindberg A., Ringnér Å., Elmrud H., Carlsson M., Runehagen A., Svanborg C., Norrby R. An epidemiologic study of Lyme disease in southern Sweden. N. Engl. J. Med. 333:1995;1319-1324.
6. Berglund J., Stjernber L., Ornstein K., Tykesson-Joelsson K., Walter H. 5-y Follow-up study of patients with neuroborreliosis. Scand. J. Infect. Dis. 34:2002;421-425.
7. Bergström S., Sjöstedt A., Dotevall L., Kaijser B., Ekstrand-Hammarström B., Wallberg C., Skogman G., Barbour A.G. Diagnosis of Lyme borreliosis by an enzyme immunoassay detecting immunoglobulin G reactive to purified Borrelia burgdorferi cell components. Eur. J. Clin. Microbiol. Infect. Dis. 10:1991;422-427.
8. Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21:1968;77-89. (Suppl.).
9. Burgdorfer W., Barbour A.G., Hayes S.F., Benach J.L., Grunwaldt E., Davis J.P. Lyme disease - a tick-borne spirochetosis? Science. 216:1982;1317-1319.
10. Busch D.H., Jassoy C., Brinckmann U., Girschick H., Huppertz H.-I. Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T cells in patients with Lyme arthritis. J. Immunol. 157:1996;3534-3541.
11. Carding S.R., Egan P.J. γδ T cells: functional plasticity and heterogeneity. Nat. Rev., Immunol. 2:2002;336-345.
12. Carter L.L., Dutton R.W. Type 1 and Type 2: a fundamental dichotomy for all T cell subsets. Curr. Opin. Immunol. 8:1996;336-342.
13. Coyle P.K., Kaufmann M.A. Latov N., Wokke J.H.J., Kelly J.J. Immunology and Infectious Diseases of the Peripheral Nerves. 1998;308-318 Cambridge Univ. Press, Cambridge.
14. Czerkinsky C., Tarkowski A., Nilsson L.-Å., Ouchterlony Ö., Nygren H., Gretzer C. Reverse enzyme-linked immunospot (RELISPOT) assay for detection of cells secreting immunoreactive substances. J. Immunol. Methods. 72:1984;489-496.
15. Dong Z., Edelstein M.D., Glickstein L.J. CD8+ T cells are activated during the early Th1 and Th2 immune responses in a murine Lyme disease model. Infect. Immun. 65:1997;5334-5337.
16. Ekerfelt C., Ernerudh J., Bunikis J., Vrethem M., Aagesen J., Roberg M., Bergström S., Forsberg P. Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-γ predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes. J. Neuroimmunol. 79:1997;155-162.
17. Ekerfelt C., Ernerudh J., Vrethem M. Th1 like responses to myelin peptides in polyneuropathy associated with monoclonal gammopathy. Clin. Exp. Immunol. 108:1997;516-522.
18. Ekerfelt C., Ernerudh J., Forsberg P., Bergström S. Augmented intrathecal secretion of interferon-γ in response to Borrelia garinii in neuroborreliosis. J. Neuroimmunol. 89:1998;177-181.
19. Ekerfelt C., Forsberg P., Svenvik M., Roberg M., Bergström S., Ernerudh J. Asymptomatic Borrelia seropositive individuals display the same incidence of Borrelia specific interferon-gamma (IFN-γ)-secreting cells in blood as patients with clinical Borrelia infection. Clin. Exp. Immunol. 115:1999;498-502.
20. Ekerfelt C., Masreliez C., Svenvik M., Ernerudh J., Forsberg P. Antibodies and T cell reactivity to Borrelia burgdorferi in asymptomatic population: a study of healthy blood donors in an inland district in the south-east of Sweden. Scand. J. Infect. Dis. 33:2001;806-808.
21. Ferrick D.A., Schrenzel M.D., Mulvania T., Hsieh B., Ferlin W.G., Lepper H. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature. 373:1995;255-257.
22. Forsberg P., Ernerudh J., Ekerfelt C., Roberg M., Vrethem M., Bergström S. The outer surface proteins of Lyme disease Borrelia spirochetes stimulate T cells to secrete interferon-gamma (IFN-gamma): diagnostic and pathogenic implications. Clin. Exp. Immunol. 101:1995;453-460.
23. Frucht D.M., Fukao T., Bogdan C., Schindler H., OShea J.J., Koyasu S. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol. 22:2001;556-560.
24. Garcia-Monco J.C., Benach J.L. Lyme neuroborreliosis. Ann. Neurol. 37:1995;691-702.
25. Girschick H.J., Huppertz H.-I., Rüssmann H., Krenn V., Karch H. Intracellular persistence of Borrelia burgdorferi in human synovial cells. Rheumatol. Int. 16:1996;125-132.
26. Godfrey D., Hammond K.J.L., Poulton L.D., Smyth M.J., Baxter A.G. NKT cells: facts, functions and fallacies. Immunol. Today. 21(11):2000;573-583. (November).
27. Greve B., Magnusson C.G., Melms A., Weissert R. Immunoglobulin isotypes reveal a predominant role of type 1 immunity in multiple sclerosis. J. Neuroimmunol. 121(1-2):2001;120-125. (Dec. 3).
28. Gross D.M., Steere A.C., Huber B.T. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J. Immunol. 160:1998;1022-1028.
29. Grusell M., Widhe M., Ekerfelt C. Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis. J. Neuroimmunol. 131:2002;173-178.
30. Hansen K., Lebech A.M. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A and M. Ann. Neurol. 30:1991;197-205.
31. Hechemy K.E., Samsonoff W.A., Harris H.L., McKee M. Adherence and entry of Borrelia burgdorferi into vero cells. J. Med. Microbiol. 36:1992;229-238.
32. Hemmer B., Pinilla C., Gran B., Marques A., Zhao Y., Simon R., McFarland H., Straus S., Houghten R.R., Martin R. VII International Conference on Lyme Borreliosis and Other Emerging Tick-Borne Diseases, Vol. Abstract Book Munich, Germany:1999;31.
33. Huppertz H.-I., Karch H., Suschke H.J., Döring E., Ganser G., Thon A., Bentas W., Group T.P.R.C. Lyme arthritis in European children and adolescents. Arthritis Rheum. 38:1995;361.
34. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., Govermann J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194:2001;669-676.
35. Jacobsen M., Cepok S., Quak E., Happel M., Gaber R., Ziegler A., Schock S., Oertel W.H., Sommer N., Hemmer B. Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain. 125:2002;538-550.
36. Keane-Myers A., Nickell S.P. T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 154:1995;1770-1776.
37. Koh D.R., Fung-Leung W.P., Ho A., Gray D., Acha-Orbea H., Mak T.W. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science. 256:1992;1210-1213.
38. Loza M.J., Perussia B. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat. Immunol. 2:2001;917-924.
39. Ma Y., Sturrock A., Weis J.J. Intracellular location of Borrelia burgdorferi within human endothelial cells. Infect. Immun. 59:1991;671-678.
40. Magnarelli L.A., Anderson J.F., Barbour A.G. Enzyme-linked immunosorbent assays for Lyme disease: reactivity of subunits of Borrelia burgdorferi. J. Infect. Dis. 159:1989;43-49.
41. Mincheva-Nilsson L., Nagaeva O., Sundqvist K.-G., Hammarström M.-L., Hammarström S., Baranov V. γδ T cells of human early pregnancy decidua: evidence for cytotoxic properties. Int. Immunol. 12:2000;585-596.
42. Montgomery R., Nathanson M.H., Malawista S.E. The fate of Borrelia burgdorferi, the agent of Lyme disease, in mouse macrophages. J. Immunol. 150:1993;909-915.
43. Moody D.B., Besra G.S., Wilson I.A., Porcelli S.A. The molecular basis of CD1-mediated presentation of lipid antigens. Immunol. Rev. 172:1999;285-296.
44. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., Moretta L. Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14:1996;619-648.
45. Murray P.D., Pavelko K.D., Leibowitz J., Lin X., Rodriguez M. CD4+ and CD8+ T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J. Virol. 72:1998;7320-7329.
46. Oksi J., Kalimo H., Marttila R.J., Marjamäki M., Sonninen P., Nikoskelainen J., Viljanen M.K. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain. 119:1996;2143-2154.
47. Oksi J., Savolainen J., P'ene' J., Bousquet J., Laippala P., Viljanen M.K. Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis. Infect. Immun. 64:1996;3620-3623.
48. Oschmann P., Dorndorf W., Hornig C., Schafer C., Wellensiek H.J., Pflughaupt K.W. Stages and syndromes of neuroborreliosis. J. Neurol. 245:1998;262-272.
49. Pachner A.R., Delaney E., Oneill T. Neuroborreliosis in the nonhuman primate: Borrelia burgdorferi persists in the central nervous system. Ann. Neurol. 38:1995;667-669.
50. Paludan S.R. Interleukin-4 and interferon-γ: the quintessence of a mutual antagonistic relationship. Scand. J. Immunol. 48:1998;459-468.
51. PetriSeiler K., Weis J.J. Immunity to Lyme disease: protection, pathology and persistence. Curr. Opin. Immunol. 8:1996;503-509.
52. Reimann J. Alternative pathways for processing exogenouus and endogenous antigens that can generate peptides for MHC class I-restricted presentation. Immunol. Rev. 172:1999;131-152.
53. Rittig M.G., Häupl T., Burmester G.R. Coiling phagocytosis: a way for MHC I presentation of bacterial antigens? Int. Arch. Allergy Immunol. 103:1994;4-10.
54. Rittig M.G., Häupl T.H., Krause A., Kressel M., Groscurth P., Burmester G.R. Borrelia burgdorferi-induced ultrastructural alterations in human phagocytes: a clue to pathogenicity? J. Pathol. 173:1994;269-282.
55. Sander B., Andersson J., Andersson U. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev. 119:1991;65-93.
56. Shoberg R.J., Thomas D.D. Borrelia burgdorferi vesicles production occurs via a mechanism independent of immunoglobulin M involvement. Infect. Immun. 63:1995;4857-4865.
57. Spellberg B., Edwards J.E. Type1/Type 2 immunity in infectious diseases. Clin. Infect. Dis. 32:2001;76-102.
58. Steere A.C. Lyme disease. N. Engl. J. Med. 321:1989;586-595.
59. Stenger S., Mazzaccaro R.J., Uyemura K., Cho S., Barnes P.F., Rosat J.P., Sette A., Brenner M.B., Porcelli S.A., Bloom B.R., Modlin R.L. Differential effects of cytolytic T cell subsets on intracellular infection. Science. 276:1997;1684-1687.
60. Sun D., Whitaker J.N., Huang Z., Liu D., Coleclough C., Wekerle H., Raine C.S. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166:2001;7579-7587.
61. Szczepanski A., Benach J.L. Lyme borreliosis: host responses to Borrelia burgdorferi. Microbiol. Rev. 55:1991;21-34.
62. Ulanova M., Tarkowski A., Hahn-Zoric M., Hanson L.Å. Participation of CD1 molecules in the presentation of bacterial protein antigens in humans. Scand. J. Immunol. 50:1999;387-393.
63. Vrethem M., Hellblom L., Widlund M., Ahl M., Danielsson O., Ernerudh J., Forsberg P. Chronic symptoms are common in patients with neuroborreliosis - a questionnaire follow-up study. Acta Neurol. Scand. 106:2002;205-208.
64. Wang W.-Z., Fredriksson S., Sun J.-B., Link H. Lyme neuroborreliosis: evidence for persistent up-regulation of Borrelia burgdorferi-reactive cells secreting interferon-γ Scand. J. Immunol. 42:1995;694-700.
65. Wang W.-Z., Fredrikson S., Xiao B.-G., Kostulas V., Link H. Lyme neuroborreliosis: cerebrospinal fluid contains myelin protein-reactive cells secreting interferon-γ Eur. J. Neurol. 3:1996;122-129.
66. Weigelt W., Schneider T., Lange R. Sequence homology between spirochaete flagellin and human myelin basic protein. Immunol. Today. 13:1992;279-280.
67. Wick M.J., Ljunggren H.-G. Processing of bacterial antigens for peptide presentation on MHC class I molecules. Immunol. Rev. 172:1999;153-162.
68. Widhe M., Ekerfelt C., Forsberg P., Bergström S., Ernerudh J. IgG subclasses in Lyme borreliosis: a study of specific IgG subclass distribution in an IFN-γ predominated disease. Scand. J. Immunol. 47:1998;575-581.
69. Widhe M.E.A., Grusell M., Ekerfelt C., Vrethem M., Forsberg P., Ernerudh J. Cytokines in Lyme borreliosis: lack of early TNFα and TGFβ1 responses are associated with chronic neuroborreliosis. Immunology. 107:2002;46-55.
70. Yin Z., Siegert S., Neure L., Grolms M., Liu L., Eggens U., Radbruch A., Braun J., Siepner J. The elevated ration of interferon gamma-/interleukin-4- positive T cells found in synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta. Rheumatology. 38:1999;1058-1067.
71. Yssel H., Shanafelt M.-C., Soderberg C., Schneider P.V., Anzola J., Peltz G. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J. Exp. Med. 174:1991;593-601.